Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission | Zendy

AI Assistant Blog Pricing

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.